We provide you with 20 years of free, institutional-grade data for CRIS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CRIS. Explore the full financial landscape of CRIS stock.
| Reported Date | CIK | Ticker | Type |
|---|
Curis, Inc(NASDAQ:CRIS) 
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment o...
Website: http://www.curis.com
Founded: 2000
Full Time Employees: 28
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CRIS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.